We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in the Cards for Healthpeak Properties This Earnings Season?
Read MoreHide Full Article
Key Takeaways
Healthpeak is expected to report higher Q2 revenues, while FFOA per share may decline.
Lab demand and rising senior healthcare spending could support Healthpeak's quarterly performance.
High interest expenses and competition may pressure rents and profitability.
Healthpeak Properties, Inc. (DOC - Free Report) is slated to report its second-quarter 2026 results on Aug. 4, after market close. While the company’s quarterly results are likely to display a rise in revenues year over year, funds from operations as adjusted (FFOA) per share is expected to decline.
In the last reported quarter, this healthcare real estate investment trust (REIT) posted an FFOA per share of 45 cents, which beat the Zacks Consensus Estimate by 4.7%. Results reflected better-than-anticipated revenues. The quarter’s performance benefited from steady leasing activity, along with the Janus Living IPO and active capital allocation.
In the preceding four quarters, Healthpeak’s FFOA per share, surpassed the Zacks Consensus Estimate on three occasions and met in the remaining period, with the average beat being 2.83%. The graph below depicts this surprising history:
Healthpeak Properties, Inc. Price and EPS Surprise
Long-term growth in biopharma research and drug development supports the demand outlook for specialized lab real estate. Healthpeak’s focus on the lab segment is strategically aligned with this tailwind and may have aided its performance in the to-be-reported quarter.
Moreover, the senior citizen population is on the rise, and the healthcare expenditure for this age cohort is generallly higher than that of the overall population. Healthpeak’s life plan communities, formerly known as continuing care retirement communities, are anticipated to have benefited from this positive expenditure trend, supporting the segment’s quarterly performance.
However, high interest expenses during the second quarter are likely to have been a spoilsport for Healthpeak. The company’s operators contend with peers for occupancy. This would have likely hurt Healthpeak’s power to raise rents and affect revenues and profitability.
DOC’s Projections for Q2
The Zacks Consensus Estimate for second-quarter total revenues is pegged at $726.16 million, indicating a rise of 4.6% from the year-ago reported number.
Before the second-quarter earnings release, the company’s activities were inadequate to gain analysts’ confidence. The Zacks Consensus Estimate for the quarterly FFOA per share has remained unchanged at 44 cents over the past three months. The figure suggests a 4.4% fall from the year-ago quarter’s tally.
What Our Quantitative Model Predicts for Healthpeak
Our proven model does not conclusively predict a surprise in terms of FFOA per share for DOC this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFOA beat, which is not the case here.
Healthpeak currently has an Earnings ESP of 0.00% and a Zacks Rank of #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two stocks from the broader REIT industry — Host Hotels & Resorts (HST - Free Report) and Lamar Advertising (LAMR - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
LAMR is scheduled to report quarterly numbers on Aug. 6. The company has an Earnings ESP of +0.22% and a Zacks Rank of 3.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.
View the Zacks #1 Rank List
Image: Bigstock
What's in the Cards for Healthpeak Properties This Earnings Season?
Key Takeaways
Healthpeak Properties, Inc. (DOC - Free Report) is slated to report its second-quarter 2026 results on Aug. 4, after market close. While the company’s quarterly results are likely to display a rise in revenues year over year, funds from operations as adjusted (FFOA) per share is expected to decline.
In the last reported quarter, this healthcare real estate investment trust (REIT) posted an FFOA per share of 45 cents, which beat the Zacks Consensus Estimate by 4.7%. Results reflected better-than-anticipated revenues. The quarter’s performance benefited from steady leasing activity, along with the Janus Living IPO and active capital allocation.
In the preceding four quarters, Healthpeak’s FFOA per share, surpassed the Zacks Consensus Estimate on three occasions and met in the remaining period, with the average beat being 2.83%. The graph below depicts this surprising history:
Healthpeak Properties, Inc. Price and EPS Surprise
Healthpeak Properties, Inc. price-eps-surprise | Healthpeak Properties, Inc. Quote
Factors at Play for Healthpeak
Long-term growth in biopharma research and drug development supports the demand outlook for specialized lab real estate. Healthpeak’s focus on the lab segment is strategically aligned with this tailwind and may have aided its performance in the to-be-reported quarter.
Moreover, the senior citizen population is on the rise, and the healthcare expenditure for this age cohort is generallly higher than that of the overall population. Healthpeak’s life plan communities, formerly known as continuing care retirement communities, are anticipated to have benefited from this positive expenditure trend, supporting the segment’s quarterly performance.
However, high interest expenses during the second quarter are likely to have been a spoilsport for Healthpeak. The company’s operators contend with peers for occupancy. This would have likely hurt Healthpeak’s power to raise rents and affect revenues and profitability.
DOC’s Projections for Q2
The Zacks Consensus Estimate for second-quarter total revenues is pegged at $726.16 million, indicating a rise of 4.6% from the year-ago reported number.
Before the second-quarter earnings release, the company’s activities were inadequate to gain analysts’ confidence. The Zacks Consensus Estimate for the quarterly FFOA per share has remained unchanged at 44 cents over the past three months. The figure suggests a 4.4% fall from the year-ago quarter’s tally.
What Our Quantitative Model Predicts for Healthpeak
Our proven model does not conclusively predict a surprise in terms of FFOA per share for DOC this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an FFOA beat, which is not the case here.
Healthpeak currently has an Earnings ESP of 0.00% and a Zacks Rank of #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks That Warrant a Look
Here are two stocks from the broader REIT industry — Host Hotels & Resorts (HST - Free Report) and Lamar Advertising (LAMR - Free Report) — that you may want to consider, as our model shows that these have the right combination of elements to report a surprise this quarter.
Host Hotels is slated to report quarterly numbers on Aug. 5. HST has an Earnings ESP of +1.73% and carries a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
LAMR is scheduled to report quarterly numbers on Aug. 6. The company has an Earnings ESP of +0.22% and a Zacks Rank of 3.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO) — a widely used metric to gauge the performance of REITs.